Skip to main content
Clinical Trials/IRCT20200720048146N1
IRCT20200720048146N1
Not yet recruiting
Phase 1

Comparison of sedation effect of midazolam and muscle haloperidol in treatment of agitation of patients

Zahedan University of Medical Sciences0 sites120 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Agitation.
Sponsor
Zahedan University of Medical Sciences
Enrollment
120
Status
Not yet recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Zahedan University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Includes age 15 to 60 years
  • Score above 28 on the agitation measurement scale

Exclusion Criteria

  • Patient dissatisfaction (or legal partner)
  • Unstable vital signs (blood pressure less than 90 mm Hg, heart rate below 60 and above 120 beats per minute, oxygen saturation level below 90%, level of consciousness less than agitation)
  • History of heart disease and liver and kidney failure
  • Pregnancy and lactation
  • The patient is very restless and has the potential to harm himself and others and can not wait for a response to intramuscular injection of the drug.
  • Poisoning with an unknown drug
  • A history of active seizures requires medication
  • Myasthenia Gravis
  • Bone marrow suppression
  • Patients with coagulation disorders such as hemophilia in whom intramuscular injection is contraindicated

Outcomes

Primary Outcomes

Not specified

Similar Trials